Tech Company Financing Transactions
Edimer Pharmaceuticals Funding Round
On 3/31/2012, Edimer Pharmaceuticals raised $5.7 million in financing from Third Rock Ventures.
Transaction Overview
Company Name
Announced On
3/31/2012
Transaction Type
Venture Equity
Amount
$5,682,000
Round
Undisclosed
Investors
Third Rock Ventures (Cary Pfeffer)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
55 Cambridge Pkwy. 102W
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Edimer is dedicated to developing EDI200 as a treatment for X-linked Hypohidrodic Ectodermal Dysplasia (XLHED). Learn more edimerpharma.com and XLHEDnetwork.com
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Kirby
VP - Operations
Ramsey Johnson
Browse more venture capital transactions:
Prev: 3/31/2012: Diagnovus venture capital transaction
Next: 3/31/2012: Banjo venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs